Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- Check2 days agoChange DetectedA collaborator/publication listing was updated (including replacing an older bibliographic/online-ahead-of-print reference with a newer citation variant and updating the formatting of the collaborator name). The page’s revision/version label was also updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedPadua, Italy, Padova entry was removed and Padova, Italy, Padova entry was added in the locations list. The city name is now consistently listed as Padova.SummaryDifference0.0%

- Check30 days agoChange DetectedNaples, Italy, 80131 was added as a participating site. Napoli, Italy, 80131 was removed as a participating site.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check52 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. The update does not alter study details or other content visible on the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.